GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
---|
ALCAM | 400 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HN13 | NA | SFA and Western Blotting followed by qRT-PCR | NA | 0.48 | 0.0583 | 28279658
|
ALCAM | 400 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HN13 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.0583 | 23903875
|
ITGA6 | 6142 | HTM/LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HN13 | NA | SFA followed by Proteomics and Western Blotting | Up | 0.36 | 0.0265 | 23903875
|
ITGB4 | 6158 | HTM/LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HN13 | NA | SFA followed by Proteomics and Western Blotting | Up | 0.36 | 0.0074 | 23903875
|
NOMO1 | 30060 | HTM/LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HN13 | NA | SFA followed by Proteomics and Western Blotting | Up | 0.36 | 0.0011 | 23903875
|
CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HN13 | NA | SFA and Western Blotting | NA | 0.28 | 1 | 28279658
|
CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HN13 | NA | SFA followed by Western Blotting | NA | 0.28 | 1 | 23903875
|
CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HN13 | NA | FACs followed by Migration assay | NA | 0.28 | 1 | 30210931
|
MYC | 7553 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HN13 | NA | SFA and Western Blotting | NA | 0.28 | 0.1304 | 28279658
|
ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HN13 | NA | ALDEFLUOR assay followed by SFA | NA | 0.12 | 0.684 | 23527004
|
KIT | 6342 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HN13 | NA | FACs followed by Migration assay | NA | 0.12 | 0.018 | 30210931
|
PROM1 | 9454 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HN13 | NA | FACs followed by Migration assay | NA | 0.12 | 0.7582 | 30210931
|